-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.ISIN US00287YCS63-
AbbvieBörse Börse MünchenISIN US00287YDA47Symbol 4AB
-
AbbvieBörse Börse FrankfurtISIN US00287YBP34Symbol 4AB
-
AbbvieBörse Börse MünchenISIN US00287YCT47
-
AbbvieBörse Tradegate System der Deutsche Börse AG (60%)ISIN US00287YCZ07Symbol 4AB
-
ABBVIE INCBörse Börse BerlinISIN US00287YBK47Symbol 4AB
-
ABBVIE INCBörse Börse DüsseldorfISIN US00287YCR80Symbol 4AB
-
ABBVIE INCBörse Quotrix System der Börse DüsseldorfISIN US00287YDB20Symbol 4AB
-
ABBVIE INCBörse Gettex System der Börse MünchenISIN XS2125913603Symbol 4AB
-
ABBVIE INCBörse Börse StuttgartISIN US00287YCU10Symbol 4AB
-
ISIN US00287YAU38Symbol ABBV
-
ISIN US00287YBY41
-
ISIN US00287YCS63Symbol 4AB
-
ISIN US00287YCY32
-
ISIN US00287YCV92
-
AbbVie Inc.Börse Bolsa Mexicana de Valore Mexiko-StadtISIN US00287YBM03
-
AbbVie Inc.Börse Bolsa de Comercio de Buenos AiresISIN US00287YBC21
-
Abbvie outperformed den DAX um +29 % vom 17.05.2016 bis 27.08.2021
Portrait der Abbvie Aktie
Das Unternehmen Abbvie aus USA beschäftigt 50.000 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Die Abbvie Aktie konnte seit dem 17.05.2016 eine Rendite von 87% erwirtschaften.
Abbvie ist in mehr als 87 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) gewichtet Abbvie mit 7,03% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Abbvie Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Abbvie am höchsten gewichtet ist Insgesamt in 87 ETFs enthalten
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
368 News & Informationen zur Abbvie Aktie
AbbVie defended on Wall Street after FDA update on Rinvoq sparked selloff (NYSE:ABBV)
The decision by the FDA to add new and updated warnings on Janus kinase ((JAK)) inhibitors, including Rinvoq (upadacitinib) marketed by AbbVie (ABBV), had an outsized impact…
Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
SHANGHAI, China and REDWOOD CITY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE:…
Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
GlobeNewswire
September 01, 2021
SHANGHAI, China and REDWOOD CITY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc….
Active Pharmaceutical Ingredients Market Size | Is Projected to Reach USD 261.28 Billion by 2026, Exhibiting a CAGR of 6.1%
Top Players Covered in the Active Pharmaceutical Ingredient Market Research Report Are Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s…
Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline is Expected to Support Growth – Forecast to 2027
/PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By…
Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline Is Expected To Support Growth – Forecast To 2027
DUBLIN, Aug. 31, 2021 /PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and d…
AbbVie: Is This Dividend Stock Overbought Or Will It Go Higher? (NYSE:ABBV)
AbbVie is a beloved 'Dividend Aristocrat' currently yielding 4.4%. But the stock also is trading around a 52-week high. See if ABBV stock will go up.
10 Dividend Aristocrats with Payout Ratio Less than 55%
In this article, we will be taking a look at 10 dividend aristocrats with payout ratio less than 55%.
The Best Pharmaceutical Stocks to Add to Your Portfolio in 2021
Over the course of the past year and a half, investors have been more focused on adding pharmaceutical stocks to bolster their portfolios.
Molecular Partners : Reports Corporate Highlights and Key Financials for H1 2021 (Form 6-K)
Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021
— Significant progress in COVID-19 trials, including positive results from healthy subjects and… | August 27, 2021
Pfizer's Covid Technology May Have Cancer Applications
GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers
10 Cheap Dividend Aristocrats to Buy Now
In this article, we will be taking a look at 10 cheap dividend aristocrats to buy now.
Best Medical Marijuana Stocks To Buy In 2021? 2 Possible Long Term Investments Right Now
Could These Be Good Long Term Investments For Your Portfolio?
Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021
— Significant progress in COVID-19 trials, including positive results from healthy subjects and COVID-19 patients, supporting the launch of ongoing…
10 Best No-Fee DRIP Stocks to Buy Now
In this article, we will be taking a look at the 10 best no-fee DRIP stocks to buy now.
Who Are Pfizer's (PFE) Main Competitors?
Pfizer's biggest competitors in the global pharmaceutical industry are Roche Holding, Eli Lilly, AbbVie, Novartis, and Merck.
Looking for Healthier Healthcare Stocks?
The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs.
Fiera Capital Corp Buys Jacobs Engineering Group Inc, The Descartes Systems Group Inc, Arista Networks Inc, Sells Churchill Downs Inc, Paycom Software Inc, Performance Food Group Co
GuruFocus Article or News written by insider and the topic is about:
5 Best Dividend Stocks to Buy Now
There’s enough for investors to worry about. But there are ways to have peace of mind when it comes to your portfolio. And these dividend stocks are just the thing…
Looking for a Healthier Healthcare ETF?
The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs.
Global Immunology Market to Surpass US$ 156,378.2 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, Aug. 24, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global Immunology market is estimated to be valued at US$ 91,850…
Davidson Kempner Capital Management LP Buys , Willis Towers Watson PLC, , Sells , Qiagen NV, RealPage Inc
GuruFocus Article or News written by insider and the topic is about:
Glenview Trust Co Buys Comcast Corp, AbbVie Inc, Jupiter Wellness Inc, Sells PulteGroup Inc, Fiserv Inc,
GuruFocus Article or News written by insider and the topic is about:
Woodley Farra Manion Portfolio Management Inc Buys Progressive Corp, Raytheon Technologies Corp, International Business Machines Corp, Sells Novartis AG, Eaton Corp PLC, General Electric Co
GuruFocus Article or News written by insider and the topic is about:
Warren Buffett Is Selling These 10 Stocks
Warren Buffett, the chief of Nebraska-based Berkshire Hathaway, is often referred to as the “Sage of Omaha” due to his incredibly successful value investing strategy that has returned, on average, …
Level Four Financial, Llc Buys Compass EMP US EQIncome 100 Enhanced Volatity Wtd, VictoryShares US 500 Enhanced Volatility Wtd ETF, Alphabet Inc, Sells Amplify Transformational Data Sharing ETF, The S
GuruFocus Article or News written by insider and the topic is about:
Fishman Jay A Ltd Buys Paysafe, AbbVie Inc, Bristol-Myers Squibb Company, Sells Macquarie Infrastructure Corp, Bausch Health Inc, Cisco Systems Inc
GuruFocus Article or News written by insider and the topic is about:
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs.
Noteables: The largest company by market cap to set a new 52-week high was …
500+ Aktien mit hoher Dividende September 2021 Liste! 5%+ Dividendenrendite!
Du suchst Aktien mit hoher Dividende? In folgendem Artikel findest du 62 Aktien mit über 5% Dividendenrendite! Auch als Excel Download mit Kennzahlen!
114 Aktien mit +25 Jahre Dividendenerhöhung aus den USA und Europa
Dividenden Aristokraten sind Aktien, welche mind. 25 Jahre lang Dividende zahlen und diese jedes Jahr erhöhen konnten. 114 Aktien aus US + EU erfüllen die Kriterien
SWS Partners Buys PureCycle Technologies Inc, Etsy Inc, Cloudflare Inc, Sells Marvell Technology Inc, Wayfair Inc, Salesforce.com Inc
GuruFocus Article or News written by insider and the topic is about:
10 Stocks that Helped Warren Buffett Make $4.6 Billion in Dividends
In this article, we will be taking a look at 10 dividend stocks that helped Warren Buffett make $4.6 billion in dividends.
Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
SAN FRANCISCO, Aug. 20, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…
Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis – Forecast to 2026
DUBLIN, Aug. 19, 2021 /PRNewswire/ — The 'Global Atopic Dermatitis Drugs Market (2021-2026) by Drug Class, Route of Administration, Geography, Co…
Waycross Partners, Llc Buys AbbVie Inc, Citigroup Inc, Intuit Inc, Sells PulteGroup Inc, Pioneer Natural Resources Co, General Electric Co
GuruFocus Article or News written by insider and the topic is about:
Dermal Facial Fillers Market | Evolving Opportunities with AbbVie Inc. and Anika Therapeutics Inc. | Technavio
/PRNewswire/ — The dermal facial fillers market size is expected to reach a value of USD 1.45 billion at a CAGR of 9.14%, during 2021-2025. This marks a…
AbbVie wins court decision upholding Imbruvica patents (NYSE:ABBV)
AbbVie <> has won a court ruling that upheld four patents linked to the cancer drug Imbruvica
AbbVie Stock: Bull Thesis Strengthened By Marginal ROCE Results (NYSE:ABBV)
I analyze AbbVie by examining its marginal efficiency of capital to gauge the future direction of its profitability. See how this strengthens my bullish thesis.